View source for Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines

{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|-
| colspan="1" style="text-align:center; background:DarkGray" |'''ICD Guidelines<br> Microchapters'''
|- bgcolor="LightGrey"
!
|- bgcolor="Coral"
!
[[ICD|ICD Main Page]]
|- 
!
|-
| colspan="1" style="text-align:center; background:LightCoral" | '''Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities'''
|- 
!

|- bgcolor="Pink"
!
[[ICD guidelines|Implantable Cardioverter-Defibrillators]]
|- 
!

|- bgcolor="Pink"
!
[[ICD in pediatric patients with congenital heart disease|Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease]]
|- 
!

|-
| colspan="1" style="text-align:center; background:CornFlowerBlue" | '''Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials'''
|- 
!

|- bgcolor="LightSkyBlue"
!
[[ICD in the context of abnormal troponin|ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction]]
|- 
!

|- bgcolor="LightSkyBlue"
!
[[ICD implantation within 40 days of myocardial infarction|ICD Implantation Within 40 Days of a Myocardial Infarction]]
|- 
!

|- bgcolor="LightSkyBlue"
!
[[ICD within 90 days of revascularization|ICD Implantation Within 90 Days of Revascularization]]
|- 
!

|- bgcolor="LightSkyBlue"
!
[[ICD less than 9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation Less Than 9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]]
|- 
!
|}